Klin Farmakol Farm. 2010;24(1):34-37
Why is vaccination against tick-borne meningoencephalitis suitable?
- Emeritní profesor, 1. infekční klinika 2. LF UK, FN Na Bulovce, Praha
Until the 1940s, tick-borne encephalitis had been unknown. However, it has spread from natural reservoirs in Central Europe to nearly
all countries of the continent and about ten thousand cases of the disease are reported annually. The three virus subtypes are nearly
identical immunologically but, clinically, the course of the infection spread by Ixodes ricinus ticks is much more benign than that of infections
transmitted by Ixodes scapularis ticks in Siberia and Far East. The ultimate prevention from the infection is immunization with an
inactivated vaccine that is safe and effective. However, the vaccination rate in the population of the Czech Republic is very low; therefore,
hundreds of cases of the disease occur here whereas in neighbouring Austria where more than 90 % of the population are vaccinated,
only tens of cases of meningoencephalitis occur annually.
Keywords: tick-borne meningoencephalitis virus, ticks, attenuated vaccine, inactivated vaccine
Published: May 1, 2010 Show citation
References
- Schneider H. Üeber epidemische acute, ,Meningitis serosa". Wien Klin Wchschr 1931; 44: 350-352.
- Gallia F, Rampas J, Hollender L. Laboratorní infekce encefalitickým virem. Čas Lék čes 1949; 88: 224-229.
- Verlinde J, van Taugeren HAE, Pattyn SR, Rosenkranz A. Virus meningoencephalitis in Austria. 3. Pathogenetic and immunological properties of the virus. Bull WHO 1955; 12: 565-569.
- Danielová V. Epidemiologie klíšťové encefalitidy. Zdrav noviny Diagnóza 2000; 5: 8.
- Heinz FX. Molecular aspects of TBE virus research. Vaccine 203; 21(1): 3-10.
- Holzmann H, Vorobyova MS, Landyshenskaya IP, et al. Molecular epidemiology of tick-borne encefalitis virus: cross protection between European and far Eastern serotypes. Vaccine 1992; 10: 345-349.
Go to original source... 
Go to PubMed... - Daněk L. Vakcíny proti klíšťové meningoencefalitidě. Zdrav noviny Diagnóza 2000; 5: 9.
- Kunz C. TBE vaccination and Austrian experience. Vaccine 2003; 21(1): 50-55. Go to original source... Go to PubMed...
- Kunz C, Hofmann H, Stary A. Field studies with a new tick-borne encefalitis (TBE) vaccine. Zbl Bact Orig A 1976; 243: 141-144.
- Heinz FX, Kunz C, Fauma H. Preparation of highly purified vaccine against tick-borne encefalitis by continous flow zonal centrifugation. J Med Virol 1980; 6: 213-221. Go to original source... Go to PubMed...
- Bok H, Klockmann U, Juengst C, et al. A new vaccine against tick-borne encefalitis: initial trial in man including a dose-response study. Vaccine 1990; 8: 22-24. Go to original source... Go to PubMed...
- Girsgdies OE, Rosenkranz G. Tick-borne encefalitis development of a pediatric vaccine. A controlled, randomised, double-blind and multicentre study. Vaccine 1996; 14: 1421-1428. Go to original source... Go to PubMed...
- Beran J, Jilg W, Mach T, Banzhoff A. A clinical evolution of a polygelin-free TBE vaccine for adolescents and adults. Vaccine 2003; 21: 738-741. Go to original source... Go to PubMed...
- Zent O, Banzhoff A, Hilbert AK, et al. Safety, immunogenicity and tolerability of a pediatric tick-borne encefalitis (TBE) vaccine, free of protein-derived stabiliser. Vaccine 2003; 21: 3584-3592. Go to original source... Go to PubMed...
- Havlík J. Klíšťová encefalitida a jak nákaze předejít. Postgraduální medicina 2006; 8(3): 926-929.
- Havlík J. Vliv očkování na výskyt klíšťové meningoencefalitidy v České republice. Postgraduální medicina 2009; 11(6): 615-618.